Defendant Name:
Northwest Biotherapeutics, Inc.
Defendant Type:
Public Company
Document Reference:
34-87281-s
Document Details
Legal Case Name
In the Matter of Northwest Biotherapeutics, Inc.
Document Name
SEC Files Settled Action Against Biotechnology Company Related to Unremediated Material Weaknesses Spanning Twelve Years
Document Date
10-Oct-2019
Document Format
Administrative Proceeding
Allegation Type
Issuer Reporting and Disclosure
Document Summary
The SEC stated that: "[It] filed a settled action against Northwest Biotherapeutics (NWBO) for failing to maintain internal control over financial reporting (ICFR) for twelve consecutive annual reporting periods. In each of its annual Form 10-K filings with the Commission over more than a decade, NWBO disclosed material weaknesses, many of which recurred year after year, with insufficient effort at remediation."
Disgorgement & Penalty Information
Resolutions
Cease and Desist Order
Compliance Related Independent Consultant
Monetary Penalties:
Civil Penalty
Individual:
$250,000.00
Shared: